Shares of Zosano Pharma Corporation (NASDAQ:ZSAN) were down 1.4% during trading on Tuesday . The company traded as low as $0.57 and last traded at $0.68. Approximately 393,200 shares were traded during mid-day trading, a decline of 75% from the average daily volume of 1,570,178 shares. The stock had previously closed at $0.69.
Separately, ValuEngine upgraded Zosano Pharma Corporation from a “strong sell” rating to a “sell” rating in a research note on Friday, September 1st.
Zosano Pharma Corporation (NASDAQ:ZSAN) last issued its earnings results on Thursday, November 9th. The biotechnology company reported ($0.20) EPS for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.05). analysts forecast that Zosano Pharma Corporation will post -0.79 EPS for the current fiscal year.
About Zosano Pharma Corporation
Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers consistent drug delivery and improved ease of use and room-temperature stability.
Receive News & Ratings for Zosano Pharma Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zosano Pharma Corporation and related companies with MarketBeat.com's FREE daily email newsletter.